Who wuda thunk?
"Pyng Medical Corp Named to The TSX Venture 50, the First Ever Ranking of Canada's Top Emerging Companies
Ticker Symbol: PYT PYNGF
RICHMOND, BC -- (MARKET WIRE) -- 12/12/05
Pyng Medical Corp (TSX-V: PYT) (OTC BB: PYNGF) is pleased to announce that the company was selected by the Toronto Stock Venture Exchange for the inaugural Venture 50. The Venture 50 showcases the top ten companies in each of the five major industry sectors covered by the TSX Venture Exchange, Mining, Oil and Gas, Technologies, Life Sciences and Diversified Industries.
The independent selection process is based on a ranking formula with equal weight being given to annual revenue, return on investment, growth in market capitalization and trading volume.
Pyng Medical Corp was selected, based upon the above criteria, as the third highest ranked company across Canada in Life Sciences and awarded a Certificate at a ceremony held at the Toronto Stock Exchange December 6th, 2005. There are nearly 2000 companies listed on TSX Venture Exchange.
Michael W. Jacobs, CEO and Founder of Pyng Medical Corp, attended the ceremony stating, "Being selected for the TSX Venture Exchange Venture 50 is indeed an honor for our company and salutes the excellent results achieved on all fronts by the dedicated staff of Pyng Medical Corp in fiscal 2005 as well as recognizing the on going acceptance, Internationally, of the F.A.S.T.1 System for Adult Intraosseous Infusion."
Worldwide revenue from Pyng Medical's award winning F.A.S.T.1(TM) System for rapid vascular access in shock and trauma patients has increased in excess of 50% per year over the last four years with fiscal 2006 projected to match and/or exceed that performance.
The Venture 50 selection will provide major publicity for the company in several newspapers and also Profit magazine.
For further information please contact Pyng Medical Corp. at 1-604-303-7964 or visit our web site at www.pyng.com
Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections.
All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.
Distributed by Filing Services Canada and retransmitted by Market Wire
Michael W. Jacobs
Chairman, Pyng Medical Corp
1-604-303-7964
www.pyng.com" |
